Polymorphisms of the IL12B and IL23R genes are associated with psoriasis.

Psoriasis is a common inflammatory and hyperproliferative skin disease with a multifactorial genetic basis. A recent study reported that psoriasis was associated with the IL12B haplotype rs3212227 (3'-untranslated region)-rs6887695 (60 kb, 5') and the IL23R haplotype rs7530511 (L310P)-rs11209026 (Q381R). We examined these four single-nucleotide polymorphisms (SNPs) for association with psoriasis in two groups of North American and German Caucasians: (1) 1,810 cases and 2,522 controls; and (2) 509 pedigrees. Both IL12B markers showed highly significant association with psoriasis in the case-control (rs3212227, odds ratio (OR)=1.62, P=1.7 x 10(-15); rs6887695, OR=1.49, P=2.7 x 10(-15)) and in the family-based analysis (rs3212227, P=2.2 x 10(-3); rs6887695, P=1.7 x 10(-3)). The IL23R SNPs also showed significant association in the cases and controls (rs7530511, OR=1.22, P=3.9 x 10(-3); rs11209026, OR=1.40, P=3.8 x 10(-4)). For both genes, common risk haplotypes were identified whose statistical significance approached (IL23R) or exceeded (IL12B) genome-wide criteria. We found no statistical evidence for interactions of these haplotypes with HLA-Cw6. Our results confirm associations between IL12B and IL23R and psoriasis in Caucasians, and provide a genetic basis for the clinical association between psoriasis and Crohn's disease.

[1]  D. Zaykin,et al.  Effect of Two- and Three-Locus Linkage Disequilibrium on the Power to Detect Marker/Phenotype Associations , 2004, Genetics.

[2]  D. Middleton,et al.  Genetic polymorphism of IL-12 p40 gene in immune-mediated disease , 2000, Genes and Immunity.

[3]  James T. Elder,et al.  Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. , 1997, Human molecular genetics.

[4]  D. Gladman,et al.  CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. , 2003, American journal of human genetics.

[5]  Stefan Jenisch,et al.  Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. , 2006, American journal of human genetics.

[6]  G. Abecasis,et al.  A note on exact tests of Hardy-Weinberg equilibrium. , 2005, American journal of human genetics.

[7]  H. Cordell.  Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. , 2002, Human molecular genetics.

[8]  M. Dhodapkar,et al.  Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris , 2004, The Journal of experimental medicine.

[9]  James T. Elder,et al.  Scanning chromosome 17 for psoriasis susceptibility: lack of evidence for a distal 17q locus. , 1995, Human heredity.

[10]  Steven J. Schrodi,et al.  A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. , 2007, American journal of human genetics.

[11]  N. Laird,et al.  The family based association test method: strategies for studying general genotype–phenotype associations , 2001, European Journal of Human Genetics.

[12]  A. Reis,et al.  Lack of genetic association of the three more common polymorphisms of CARD15 with psoriatic arthritis and psoriasis in a German cohort , 2004, Annals of the rheumatic diseases.

[13]  Lawrence Steinman,et al.  A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2007, Nature Medicine.

[14]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[15]  Thomas Lumley,et al.  Simple estimates of haplotype relative risks in case‐control data , 2006, Genetic epidemiology.

[16]  M. Lebwohl,et al.  A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. , 2007, The New England journal of medicine.

[17]  Frank O. Nestle,et al.  Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis , 2007, Human Genetics.

[18]  R. Elston,et al.  Improving power in contrasting linkage-disequilibrium patterns between cases and controls. , 2007, American journal of human genetics.

[19]  J. Hugot.  CARD15/NOD2 Mutations in Crohn's Disease , 2006, Annals of the New York Academy of Sciences.

[20]  Koichiro Nakamura,et al.  Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. , 2002, Journal of dermatological science.

[21]  Mario Albrecht,et al.  Genetics of Crohn disease, an archetypal inflammatory barrier disease , 2005, Nature Reviews Genetics.

[22]  Dmitri V Zaykin,et al.  Contrasting linkage-disequilibrium patterns between cases and controls as a novel association-mapping method. , 2006, American journal of human genetics.

[23]  James T. Elder,et al.  Lack of association between NOD2 3020InsC frameshift mutation and psoriasis. , 2001, The Journal of investigative dermatology.

[24]  O. Boyman,et al.  The pathogenic role of tissue-resident immune cells in psoriasis. , 2007, Trends in immunology.

[25]  S. Kingsmore,et al.  Protein Microarray Analysis of Disease Activity in Pediatric Inflammatory Bowel Disease Demonstrates Elevated Serum PLGF, IL-7, TGF-β1, and IL-12p40 Levels in Crohn's Disease and Ulcerative Colitis Patients in Remission versus Active Disease , 2005, The American Journal of Gastroenterology.

[26]  J. Bos,et al.  In Vitro and In Situ Expression of IL-23 by Keratinocytes in Healthy Skin and Psoriasis Lesions: Enhanced Expression in Psoriatic Skin , 2006, The Journal of Immunology.

[27]  B. Weir,et al.  Digenic descent measures for finite populations , 1977 .

[28]  B. Weir,et al.  A classical setting for associations between markers and loci affecting quantitative traits. , 1999, Genetical research.

[29]  F. I. Lee,et al.  Increased occurrence of psoriasis in patients with Crohn's disease and their relatives. , 1990, The American journal of gastroenterology.

[30]  A. Agresti,et al.  Categorical Data Analysis , 1991, International Encyclopedia of Statistical Science.

[31]  Chiara Sabatti,et al.  The use of pedigree, sib-pair and association studies of common diseases for genetic mapping and epidemiology , 2004, Nature Genetics.

[32]  E. Christophers,et al.  Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. , 1985, Journal of the American Academy of Dermatology.

[33]  T. Mcclanahan,et al.  IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. , 2006, The Journal of clinical investigation.

[34]  James T. Elder,et al.  CARD15 mutations in patients with plaque-type psoriasis and psoriatic arthritis: lack of association , 2006, Archives of Dermatological Research.

[35]  A. Gottlieb,et al.  Connections between psoriasis and Crohn's disease. , 2003, Journal of the American Academy of Dermatology.

[36]  Y. Chang,et al.  Cytokine gene polymorphisms in Chinese patients with psoriasis , 2007, The British journal of dermatology.

[37]  Bruce S. Weir,et al.  Genetic Data Analysis: Methods for Discrete Population Genetic Data. , 1991 .

[38]  Pairwise linkage disequilibrium under disease models , 2007, European Journal of Human Genetics.

[39]  D J Schaid,et al.  Evaluation of candidate genes in case-control studies: a statistical method to account for related subjects. , 2001, American journal of human genetics.

[40]  James G. Krueger,et al.  Pathogenesis and therapy of psoriasis , 2007, Nature.

[41]  B. Nickoloff.  Cracking the cytokine code in psoriasis , 2007, Nature Medicine.

[42]  S. Chimenti,et al.  Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population. , 2004, The Journal of investigative dermatology.

[43]  Xin Xu,et al.  Family‐based tests for associating haplotypes with general phenotype data: Application to asthma genetics , 2004, Genetic epidemiology.

[44]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[45]  M. Neurath,et al.  Anti-interleukin-12 antibody for active Crohn's disease. , 2004, The New England journal of medicine.

[46]  B. Weir,et al.  Properties of the Multiallelic Trend Test , 2004, Biometrics.

[47]  H. Cordell.  Estimation and testing of genotype and haplotype effects in case‐control studies: comparison of weighted regression and multiple imputation procedures , 2006, Genetic epidemiology.

[48]  Peter Donnelly,et al.  A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.

[49]  M. Neurath,et al.  Both IL‐12p70 and IL‐23 are synthesized during active Crohn's disease and are down‐regulated by treatment with anti‐IL‐12 p40 monoclonal antibody , 2006, Inflammatory bowel diseases.

[50]  Y. Iwakura,et al.  The IL-23/IL-17 axis in inflammation. , 2006, The Journal of clinical investigation.

[51]  A. Silman,et al.  Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritis. , 2005, Arthritis and rheumatism.

[52]  S. Fisher,et al.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations , 2001, The Lancet.

[53]  T. Mcclanahan,et al.  Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation , 2003, The Journal of experimental medicine.

[54]  Daniel Rabinowitz,et al.  A Unified Approach to Adjusting Association Tests for Population Admixture with Arbitrary Pedigree Structure and Arbitrary Missing Marker Information , 2000, Human Heredity.

[55]  M. Gilthorpe,et al.  Haplotype uncertainty in association studies , 2007, Genetic epidemiology.